Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ADMA Biologics Inc (ADMA) vs Vipshop Holdings Ltd - ADR (VIPS) Price & Performance

ADMA Biologics IncTrade
Vipshop Holdings Ltd - ADRTrade

Price performance (Past 24H)

Key statistics

ADMA Biologics Inc vs Vipshop Holdings Ltd - ADR — how do they compare? ADMA Biologics Inc trades at $9.88 (market cap $2.18B), while Vipshop Holdings Ltd - ADR trades at $15.06 (market cap $7.40B). The key difference: Vipshop Holdings Ltd - ADR is far larger — about 3.4× ADMA Biologics Inc's market cap, and Vipshop Holdings Ltd - ADR pays a 4.02% dividend while ADMA Biologics Inc pays none. Which is the better fit depends on your goals.

ADMAVIPS
Market Cap
$2.18B$7.40B
Sector
HealthConsumer Cyclical
52-Week High
$20.38$20.68
52-Week Low
$7.60$12.92
Enterprise Value
$2.25B$3.97B
Dividend Yield
4.02%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ADMA Biologics Inc

ADMA trades at $9.90, down 1.59% today, with strong profitability metrics including 64.71% gross margin and 41.9% ROE. Technical indicators show a bullish trend with support at $9-10, though RSI levels suggest overbought conditions. Recent earnings show mixed results with Q4 2025 beating expectations but Q1 and Q2 2026 missing estimates. The stock faces significant legal headwinds with multiple securities fraud lawsuits filed against the company.

Despite strong fundamentals and bullish analyst consensus (88.9% buy ratings), ADMA faces substantial legal risks from ongoing securities litigation that could impact shareholder value. The company's solid profit margins and growth trajectory provide upside potential, but investors should carefully weigh litigation risks against fundamental strength.

Vipshop Holdings Ltd - ADR

Vipshop Holdings (VIPS) trades at $15.68, up 1.75% with a bullish technical signal. The stock shows attractive valuation metrics including a P/E of 7.1 and P/S of 0.5, while maintaining solid profitability with 7.07% net margin and 18.43% ROE. Recent Q1 2026 earnings met expectations, and the company is pursuing growth through outlet store strategies. Analyst consensus leans bullish with 53.57% buy ratings.

The outlook remains constructive given discounted valuation and operational efficiency, though revenue stagnation and competitive pressures in China's e-commerce sector present challenges. Positive cash flow generation and strategic initiatives support potential upside, but investors should monitor execution on growth initiatives amid economic headwinds.

Returns comparison

Trailing returns across standard periods

About ADMA Biologics Inc

ADMA Biologics is a biopharmaceutical company specializing in plasma-derived therapies for immunodeficient patients. Key products like ASCENIV and BIVIGAM treat primary humoral immunodeficiency and help prevent infectious diseases.

Read more on ADMA

About Vipshop Holdings Ltd - ADR

Vipshop Holdings Ltd is an online discount retailer for brands in China. The company offers branded products to consumers in China through flash sales on its vipshop.com, vip.com and lefeng.com websites. Flash sales represent an online retail format combining the advantages of e-commerce and discount sales through selling a finite quantity of discounted products or services online for a limited period of time. It deals in a wide range of products and services for consumers specializing in branded cosmetics, apparel, healthcare products, food and other consumer products. Its operating segment includes Vip.com and Shan Shan Outlets. The company generates maximum revenue from Vip.com segment.

Read more on VIPS